Primary effusion lymphoma after heart transplantation: A new entity associated with human herpesvirus-8

Leukemia

Volumn 13, Issue 5, 1999, Pages 664-670

  Dotti, G ^a   Fiocchi, R ^a   Motta, T ^a   Facchinetti, B ^a   Chiodini, B ^a   Borleri, G M ^a   Gavazzeni, G ^a   Barbui, T ^a   Rambaldi, A ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Body cavity based lymphoma; Human herpesvirus 8; Immunosuppression; Primary effusion lymphoma

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; STEROID; VIRUS DNA;

ADULT; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DNA SEQUENCE; GRAFT REJECTION; HEART DILATATION; HEART TRANSPLANTATION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; KARYOTYPING; LYMPHOMA; MALE; PRIORITY JOURNAL; REVIEW;

EID: 0033019321     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401390     Document Type: Review

References (35)

1. Craig FE, Gulley ML, Banks PM. Post-transplantation lymphoproliferative disorders. Am J Clin Pathol 1993; 99: 265-276.
2. Swerdlow SH. Classification of the post-transplant lymphoproliferative disorders: from the past to the present. Semin Diagn Pathol 1997; 14: 2-7.
3. Knowles DM, lnghirami G, Ubriaco A, Dalla-Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 1989; 73: 792-799.
4. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas. New Engl J Med 1995; 332: 1186-1191.
5. Nador RG, Cesarman E, Chadburn A, Dawson B, Ansari MQ, Said J, Knowles DM. Primary effusion lymphoma: a distinct clinico-pathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88: 645-656.
6. Carbone C, Gloghini A, Vaccher E, Zagonel V, Pastore V, Dalla Palma P, Branz F, Saglio G, Volpe R, Tirelli U, Gaidano G. Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusion. Br J Haematol 1996; 94: 533-543.
7. Carbone A, Gaidano G. HHV-8-positive body cavity-based lymphoma: a novel lymphoma entity. Br J Haematol 1997; 97: 515-522.
8. Gaidano G, Gioghini A, Gattei V, Rossi MF, Cilia AM, Godeas C, Degan T, Perin T, Canzonieri V, Aldinucci D, Saglio G, Carbone A, Pinto A. Association of Kaposi's sarcoma-associated herpes-virus-positive primary effusion lymphoma with expression of the CD138/sydecan-1 antigen. Blood 1997; 90: 4894-4900.
9. Nador RG, Cesarman E, Knowles DM. Herpes-like sequences in a body cavity-based lymphoma in an HIV-negative patient. New Engl J Med 1996; 333: 943.
10. Cesarman H, Nador RG, Aozasa K, Delsol G, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus in non-AIDS-related lymphomas occurring in body cavity. Am J Pathol 1996; 149: 53-57.
11. Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, Knowles DM, Koeffler HP. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 1996; 88: 3124-3128.
12. Hermine O, Michel M, Buzyn-Veil A, Gessain A. Body cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences. New Engl J Med 1996; 334: 272-273.
13. Jones D, Ballestas ME, Kaye KM, Gulizia JM, Winters GL, Fletcher J, Scadden DT, Aster JC. Primary effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. New Engl J Med 1998; 339: 444-449.
14. Den Boer ML, Zwaan CM, Pieters R, Kazemier KM, Rottier MMA, Flens MJ, Scheper RJ, Veerman AJP. Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia. Leukemia 1997; 11: 1078-1085.
15. Barch MJ (ed). The ATC Cytogenetics Laboratory Manual. Raven Press: New York, 1991.
16. Rambaldi A, Bettoni S, Tosi S, Giudici G, Schirò R, Borleri GM, Abbate M, Chiaraffino F, Colotta F, Barbui T, Biondi A. Establishment and characterization of a new granulocyte-macrophage colony-stimulating factor-dependent and IL-3-dependent human acute myeloid leukemia cell line (GF-D8). Blood 1993; 81: 1376-1383.
17. Gobbi A, Di Berardino C, Scanziani E, Garofalo A, Rivolta A, Fontana G, Rambaldi A, Giavazzi R, Biondi A. A human acute lymphoblastic leukemia line with the t(4;11) translocation as a model of minimal residual disease in SCID mice. Leukemia Res 1997; 21: 1107-1114.
18. Lo Coco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, Chaganti RSK, Dalla Favera R. Rearrangement of the Bcl-6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 1994; 83: 1757-1759.
19. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E, Epstein-Barr virus type 1 and 2 differ in their EBNA-3A, EBNA-3B and EBNA-3C genes. J Virol 1990; 64: 4084-4092.
20. Knecht H, Bachmann E, Joske DJL, Sahli R, Emery-Goodman A, Casanove JL, Zilic M, Bachmann F, Odermatt BF. Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's dosease. Leukemia 1993; 7: 580-585.
21. Gribben JG, Freedman AS, Woo SD, Blake K, Shu RS, Freeman G, Longtine JA, Pinkus GS, Nadler LM. All advanced stage non-Hodgkin's lymphoma with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275-3280.
22. Rambaldi A, Borleri GM, Dotti G, Bellavita P, Amaru R, Biondi A, Barbui T. Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation. Blood 1998; 91: 2189-2198.
23. Bassan R, Chiodini B, Lerede T, Torri V, Borleri G, Rambaldi A, Barbui T. The role of idarubicin in adult acute lymphoblastic leukaemia: from drug resistance studies to clinical application. Leuk Lymphoma 1997; 26 (Suppl. 1): 89-97.
24. Delecluse HJ, Rouault JP, Jeammont B, Kremmer E, Bastard C, Berger F. Bcl6/LAZ3 rearrangements in post-transplant lymphoproliferative disorders. Br J Haematol 1995; 91: 101-103.
25. Ansari MQ, Dawson DB, Nador R, Rutherford C, Schneider NR, Latimer MJ, Picker L, Knowles DM, McKenna RW. Primary body cavity-based AIDS-related lymphomas. Am J Clin Pathol 1996; 105: 221-229.
26. Alkan S, Karcher DS, Ortiz A, Khalil S, Akhtar M, Ali MA. Human herpesvirus-8/Kaposi's sarcoma associated herpesvirus in organ transplant patients with immunosuppression. Br J Haematol 1997; 96: 412-414.
27. Boshoff C, Whitby D, Hatziioannou T, Fisher C, van der Walt J, Hatzakis A, Robin W. Kaposi's sarcoma associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345: 1043-1044.
28. Boshoff C, Gao SJ, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA, Chang Y. Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in NOD/SCID mice. Blood 1998; 9: 1671-1679.
29. Said JW, Retting MR, Heppner K, Vescio RA, Schiller G, Ma HJ, Belson D, Savage A, Shintaku IP, Koeffler HP, Asou H, Pinkus G, Pinkus J, Schrage M, Grren E, Berenson JR. Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 1997; 90: 4276-4282.
30. Lehnert M. Clinical multidrug resistance in cancer: a multifactorial problem. Eur J Cancer 1996; 32A: 912-924.
31. Regamey N, Tamm M, Wernli M, Witschi A, Gilbert T, Cathomas G, Erb P. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. New Engl J Med 1998; 339: 1358-1363.
32. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348: 1133-1138.
33. Parravicini C, Olsen SJ, Capra Poli MF, Sirchia G, Gao SJ, Berti E, Nocera A, Rossi E, Bestetti G, Pizzuto M, Galli M, Moroni M, Moore PS, Corbellino M. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor to allografts among Italian post-transplant Kaposi's sarcoma patients. Blood 1997; 90: 2826-2829.
34. Drexler HG, Uphoff CC, Gaidano G, Carbone A. Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphoma (body cavity-based lymphomas). Leukemia 1998; 12: 1507-1517.
35. Kades DH, Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. J Clin Invest 1997; 99: 2082-2086.